RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 원문제공처
        • 등재정보
        • 학술지명
        • 주제분류
        • 발행연도
        • 작성언어
        • 저자
          펼치기

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        競爭秩序 禁止에 대한 法的檢討

        최상희(Choi Sang-Hoe) 한국법학회 2010 법학연구 Vol.37 No.-

        경쟁금지에 대한 불법행위법의 문제는 시장경제에서 중요한 의미를 갖는다. 그러나 아직까지 우리 민법에 있어서 이에 관한 연구가 충분하지 않은 것 같다. 불공정거래행위에 대해서는 독점규제 및 공정거래에 관한 법률, 부정경쟁방지 및 영업비밀보호에 관한 법률 등 특별법의 규정에 의해 규제된다. 하지만 특별법에 의해서 모든 부정경쟁행위들을 규율하기는 어렵다. 오히려 일반법인 민법의 규정 내지는 이론으로 규제되어야 한다. 만일 특별법에 의해서 불공정거래행위를 규제할 수 없다면 아마도 민법에 의한 규제를 청구할 것이다. 본고에서는 일본의 사인금지청구권에 관한 유형들을 검토하여 봄으로써 경쟁에 의한 손해의 불법행위에 대한 금지청구의 필요성을 찾으려고 하였다. 일본은 2000년 비록 제한적이긴 하지만 사인의 금지청구권을 도입하였다. 일본의 사인금지청구권에 관한 유형들과 논의를 살펴봄으로써 많은 시사점을 얻을 수 있을 것이다. The issue of the tort for an Injunction of competition has important meaning in the market economy. However, researches on this field don't seem to have been sufficient treated in the Korean civil law. Unfair competition has been regulated by application of a special statutes, such as Antitrust Law. But these special statutes to covering all the matters of unfair competition rather than civil law should be solved the competitive injury. If it is impossible to solve the problem of competitive injury through some special statutes, a claim for restrictions by civil law. In this paper attempt to search for necessary to Injunction for tort on competitive injury, in particular, to overview the private actions for an Injunction of Japan. Japan adopted private parties action for Injunction in 2000, Although it has significant limitation in its scope. This study can be obtained the implications through a type and a discussion on the private actions for an Injunction of Japan.

      • KCI등재

        정신질환자의 자상(自傷).타해(他害)사고에 대한 의료과오책임

        최상희(Choi, Sang-hoe) 충북대학교 법학연구소 2010 法學硏究 Vol.21 No.1

        In the present age, the medicine of every field progresses with rapid speed.Hereupon, the present medicine divides diversions with a specialization and collaboration on patient's medical care. Psychiatric medicine is closely related with law, moral and ethics, and conflicts interests among them. Thus, it is necessary to adjust interests and conflicts between psychiatrist and patient. Psychiatric malpractice is medical malpractice. Medical malpractice is tort, or civil wrong. Medical malpractice is professional negligence by act or omission by a health care provider in which care provided deviates from accepted standards of practice in the medical community and causes injury or death to the patient. Standards and regulations for medical malpractice vary by country and jurisdiction within countries. Medical professionals are required to maintain professional liability insurance to offset the risk and costs of lawsuits based on medical malpractice. In korea, Mental Health Act(MHA) is enacted in 1995 in order to promote mentally ill person's medical treatment and rehabilitation. Korea MHA enact various provisions for the benefit of mentally ill person. Among those, all the mentally ill persons are guaranteed human dignity and value by the law. Korea MHA promulgate voluntary admission and involuntary admission of psychiatric hospital. In advanced countries such as USA, Japan, voluntary admission is main stream form of hospitalization. But, in our country, large part of hospitalization is involuntary admission. On this point, correcting is required for the betterment of mentally ill person's human rights.

      • KCI등재

        의료과오의 민사책임

        최상희(Choi, Sang-Hoe) 충북대학교 법학연구소 2009 法學硏究 Vol.20 No.1

        Despite of the remarkable progress of medical science, the medical mistakes is on the increasing tendency. This medical mistakes between physician and patient have become serious social problem. The increase of medical mistakes is believed to be caused mainly by the lack of confidence in doctor-patient relationship. As with the development of medical technology, the increasing awareness of human rights, and the enlargement of National Health Insurance, the medical mistakes litigations are rapidly increasing in these decades. Medical Mistakes is an inaccurate or incomplete diagnosis and treatment of a disease; injury; syndrome; behavior; infection or other ailment Medical Malpractice is professional negligence by act or omission by a health care provider in which care provided deviates from accepted standards of practice in the medical community and causes injury or death to the patient. Everyone knows there is no almighty panacea in the world. Jurisdictions couldn't take parts of both sides absolutely. I dare to say that no perfect regime about this sophisticated social problem exists. But we should establish a fair and persuasive norm of conduct and judicial judgement to protect maximum interests of patients on one hand, and to guarantee physicians' right or duty to carry on their works. Standards and regulations for medical malpractice vary by country and jurisdiction within countries. Medical professionals are required to maintain professional liability insurance to offset the risk and costs of lawsuits based on medical malpractice. The one is the introduction of a medical professional liability insurance system.

      • KCI등재

        유전자변형농산물의 제조물책임

        최상희(Choi Sang-Hoe) 한국법학회 2008 법학연구 Vol.31 No.-

        유전자변형농산물이란 유전자 조작기술을 통하여 만든 작물을 말한다. 유전자조작기술은 세계인구의 증가로 인한 식량부족을 해결하기 위한 주요기술로 기대되고 있으며, 이미 많은 유전자변형농작물들이 개발되었고 상품화되어 재배되고 있다. 유전자변형농산물은 생산성 향상, 보존기간의 장기화, 질병 및 해충에 대한 저항성 등의 장점을 가지고 있다. 그러나 소비자들은 인체 및 환경에 대한 위해가능성에 대한 우려를 가지고 있다. 유전자변형농산물은 유용성도 있지만 여러 가지 위험성도 지적되고 있는 것이다. 따라서 GMO작물에 대한 안전성확보는 매우 중요한 것이다. 이 논문은 유전자변형농산물의 제조물책임법 적용문제를 다루었다. 그리고 미국의 제조물책임 리스테이트먼트와 독일 제조물책임법의 제조물 개념을 검토하였다. 제조물책임법 제2조 1항에서 제조물에 대한 의미를 제공하지만 그 의미가 유동적이므로 이 규정에서 제조물의 범위를 확장해서 생각할 필요가 있다. 결론적으로 제조물책임법 제2조 1호의 개념을 확대시켜 유전자변형농산물을 제조물책임법의 적용대상에 포함시키는 것이 바람직하다. Genetically Modified Organisms: (GMOs) is called the crops produced by genetically modified technology. New breeding method by genetic engineering is expected as a key technology to solve food shortage due to the growing word population. Many GMOs were already developed and the commercial cultivation has started. The GMOs have greater yields. longer shelf lives and stronger resistance to disease and insects. On the other hand. many NGO worry about a potential danger to environment and human health. Genetically Modified Organisms has a characteristic thing with a few merit and a variety of risk. It is very important how to guarantee the safety of GMO. This paper tries to look into the application of Products Liability of Genetically Modified Organisms. And this paper studies the concept of the word products in the Korean Products Liability with that of Products Liability Restatement published by American Law Institute 1998, and wth the European and German Law on Products Liability. Article 2(1) of product liability provides that products mean manufactured or processed moveables including other moveables or a part of immoveable properties. But the meaning of the products is in the melting pot. According to this rule. it's necessary to extend the scope of products by legal provisions. The result is desirable to broaden the scope of the concept of the word products.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼